Insmed Stock Already Was Flying High. Sanofi Takeover Buzz Lights the Afterburners.
Insmed stock jumps following a report saying Sanofi is eyeing a takeover of the biopharma company. Continue Reading…
Newsroom · 话题追踪
先读事件,再对照背景与来源。简讯可展开阅读,深度内容可进入全文。
Insmed stock jumps following a report saying Sanofi is eyeing a takeover of the biopharma company. Continue Reading…
Physician and biopharma executive brings more than 30 years of experience spanning pharmaceutical leadership, commercialization, drug pricing, reimbursement, and market access WEST…
* COSCIENS Biopharma Inc. press release [https://seekingalpha.com/pr/20726678-cosciens-biopharma-inc-reports-q3-2026-results-and-provides-update-on-convertible-debenture] (CSCI:CA…
Company Logo Capitalize on biopharma demand and single-use filtration adoption with insights into regulation, tariffs, supply-chain shifts and high-potential segments. Dublin, Nov.
Arbutus Biopharma and Genevant have expanded their patent infringement actions against Pfizer and BioNTech by adding new lawsuits in Japan and updating a Canadian case to include a…
* Hansa Biopharma press release [https://www.hansabiopharma.com/investors/financial-reports/hansa-biopharma-reports-third-quarter-and-interim-year-to-date-2026-financial-results/]…
Vor Biopharma reported third quarter 2026 results with a net loss of about US$86.73 million and basic loss per share of US$1.45, with a nine-month loss of US$369.12 million and bas…
Company Logo Capitalize on demand for automated, high-throughput and single-cell solutions, driven by personalized medicine, proteomics, genomics and biopharma research Dublin, Nov…
Company Logo Target biopharma, gene editing and sustainable agriculture; leverage regional and competitive insights to uncover revenue opportunities and guide R&D investment Dublin…
MELBOURNE, Australia and INDIANAPOLIS, Nov. 11, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") will participate in the upcoming UBS Global Biop…